Readystate Asset Management LP Vertex Pharmaceuticals Inc Call Options Transaction History

Readystate Asset Management LP

  • $3.08 Trillion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $10.8 Million - $13.3 Million
-27,400 Reduced 94.48%
1,600 $750 Million
Q1 2024

May 10, 2024
BUY
$407.69 - $446.08 $7.95 Million - $8.7 Million
19,500 Added 205.26%
29,000 $12.1 Billion
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $3.05 Million - $3.66 Million
8,900 Added 1483.33%
9,500 $3.87 Billion
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $188,652 - $211,146
600 New
600 $211 Million

Others Institutions Holding VRTX

# of Institutions
1,717
Shares Held
226M
Call Options Held
1.21M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email